Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tibetree Pain-Relieving Plaster (PRP) is a topical herbal analgesic patch derived from traditional Tibetan medicine. It is being investigated by Memorial Sloan Kettering Cancer Center as an adjunct therapy for managing localized cancer-related pain and chronic musculoskeletal pain in cancer survivors. The formulation contains 1% camphor along with six other herbal ingredients, including *Zanthoxylum bungeanum*, *Lamiophlomis rotata*, *Curcuma longa*, *Myricaria germanica*, and *Carthamus tinctorius*. Preclinical studies suggest the plaster exerts its effects through antinociceptive and anti-inflammatory mechanisms, specifically by inhibiting the 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2) pathways. It is currently being evaluated in clinical trials (e.g., the EASE study) to determine its efficacy in reducing opioid requirements and improving pain management in oncology patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tibetree Pain-Relieving Plaster.